Lotto tickets. That could be the best way to describe the broader biotech sector. Small drug developers with no cash flow are banking their entire futures on hitting a blockbuster drug. But there are a group of biotech stocks that are far from simply being like a lotto ticket – and this includes our latest pick for our Best Sector Dividend Stocks Model Portfolio.
Our pick is the owner of the best-selling drug in the world, producing billions in sales and cash flows for the biotech stock. And it continues to use that cash effectively. Our pick has been smart with M&A to not only buy existing blockbuster drugs, but also to develop a world-class pipeline for development. With new advanced therapies under its umbrella, it was natural for our pick to keep its dividend growing for nearly 50 years.
With its massive pipeline, current growth trajectories and a solid cash flow profile from its current blockbuster, our pick is poised to continue its winning ways in the healthcare sector.
You can check out the Best Sector Lists to explore all the stocks.
